SHROOM3 and glomerulosclerosis: These studies demonstrated that a defect in the actin-binding domain of SHROOM3 can result in podocyte effacement and impairment of the glomerular filtration barrier, and eventually leads to albuminuria and glomerulosclerosis (Yeo et al., 2015).